Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.75    0.00 (0.00%)
Bid:
1.61
Ask:
1.77
Spread: 0.16 (9.938%)
Market Cap: £35.11m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Morocco Update

22 May 2023 07:00

RNS Number : 1668A
Quadrise PLC
22 May 2023
 

22 May 2023

Quadrise Plc ("Quadrise" or the "Company")

Morocco Update

Quadrise Plc (AIM:QED), the supplier of innovative energy solutions for a cleaner planet, provides an update on its fuel trial in Morocco.

The industrial demonstration test commenced as planned this week in accordance with the client's production schedule. Quadrise personnel at the client site confirmed the MSAR® and bioMSAR™ fuel quality and fully commissioned the Company's pumping and heating unit ("PHU") at load.

Cold start-up of the client's combustion unit was carried out and the initial unit warm-up sequence was tested using MSAR® fuel. Unfortunately, whilst running at 100% a mechanical component in the PHU failed progressively, reducing the available unit load achievable from the Quadrise burner, and we were unable to complete the testing during May as originally planned. The parties agreed to pause the trial so that the client could complete their scheduled production run, and the respective Quadrise part could be replaced.

The replacement mechanical item concerned has been procured in the UK by Quadrise and will be sent to the client in Morocco as soon as possible. This will enable Quadrise to finalise optimisation of combustion at full load when the trial resumes.

Commenting on the update, Jason Miles, Chief Executive Officer of Quadrise, said:

 

"We are obviously disappointed not to have completed the trial during May due to an unexpected mechanical issue in our PHU. However, a replacement part has been purchased and expedited so that we can restart the operational production test at the next opportunity.

On behalf of the Quadrise team on site, we would like to thank our client in Morocco for their valuable and collaborative support during testing to date, and we look forward to returning and completing the test fully during the next production run with their team."

 

For additional information, please contact:

 

Quadrise Fuels International Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cenkos Securities plc

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

 

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate broking)

+44 (0)20 3005 5000

Public & Investor Relations

 

 

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.

 

Learn more at: www.quadrise.com

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGUGDUDSDDGXD
Date   Source Headline
26th Mar 20157:00 amRNSNotice of Full Year Results
26th Mar 20157:00 amRNSSignificant holding in Company
19th Mar 20154:30 pmRNSDirector Declaration
19th Mar 20154:30 pmRNSDirector Declaration
10th Mar 201510:00 amRNSDirectors' Shareholdings
9th Mar 20154:30 pmRNSSignificant holding in Company
3rd Mar 20154:31 pmRNSTotal Voting Rights
3rd Mar 20154:30 pmRNSDirector Shareholding
13th Feb 20157:00 amRNSQ3 Trading Update
10th Feb 20154:30 pmRNSDirectors' Shareholdings
3rd Feb 20154:30 pmRNSDirector Shareholding
3rd Feb 20154:30 pmRNSTotal Voting Rights
21st Jan 20157:00 amRNSAppointment of Finance Director
16th Jan 20154:30 pmRNSHolding(s) in Company
7th Jan 20154:30 pmRNSDirector/PDMR Shareholding
5th Jan 20154:31 pmRNSTotal Voting Rights
5th Jan 20154:30 pmRNSDirector/PDMR Shareholding
10th Dec 20144:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20144:31 pmRNSBlocklisting Interim Review
2nd Dec 20144:30 pmRNSTotal Voting Rights
2nd Dec 20144:30 pmRNSDirector/PDMR Shareholding
25th Nov 20147:00 amRNSInterim Results
10th Nov 20144:30 pmRNSDirector/PDMR Shareholding
4th Nov 20144:31 pmRNSTotal Voting Rights
4th Nov 20144:30 pmRNSDirector/PDMR Shareholding
28th Oct 20144:30 pmRNSHolding(s) in Company
28th Oct 201412:53 pmRNSNotice of Interim Results
8th Oct 20144:30 pmRNSDirector/PDMR Shareholding
7th Oct 20147:00 amRNSAnnouncement re: Board Announcement
3rd Oct 20149:31 amRNSTotal Voting Rights
3rd Oct 20149:30 amRNSDirector/PDMR Shareholding
15th Sep 201410:45 amRNSDirector/PDMR Shareholding
10th Sep 20144:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20144:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20144:30 pmRNSHolding(s) in Company
2nd Sep 20144:30 pmRNSTotal Voting Rights
22nd Aug 20144:30 pmRNSAudit Tender Outcome
8th Aug 20147:00 amRNSInterim Management Statement
7th Aug 20144:30 pmRNSDirector/PDMR Shareholding
4th Aug 20144:30 pmRNSDirector/PDMR Shareholding
4th Aug 20144:30 pmRNSTotal Voting Rights
4th Aug 20144:30 pmRNSChange of Registered Office
23rd Jul 20144:30 pmRNSHolding(s) in Company
22nd Jul 20145:29 pmRNSResult of AGM
21st Jul 20145:46 pmRNSAGM Statement
8th Jul 20145:12 pmRNSDirector/PDMR Shareholding
3rd Jul 20144:30 pmRNSHolding(s) in Company
2nd Jul 20144:30 pmRNSDirector/PDMR Shareholding
2nd Jul 20144:30 pmRNSTotal Voting Rights
30th Jun 20144:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.